It is time to include real-world effectiveness data on medicinal product labels.

Dal-Ré, Rafael; Porcher, Raphaël; Rosendaal, Frits R; Schwarzer-Daum, Brigitte

Dal-Ré, Rafael; Porcher, Raphaël; Rosendaal, Frits R; Schwarzer-Daum, Brigitte.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid E-28040, Spain. Electronic address: rafael.dalre@quironsalud.es.
Porcher R; Centre of Research in Epidemiology and Statistics, Institut National de la Santé et de la Recherche Médicale, University of Paris, Paris, France.
Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.
Schwarzer-Daum B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Lancet Respir Med ; 10(3): e28-e29, 2022 03.

Article in English | MEDLINE | ID: covidwho-2211774

Subject(s)

Product Labeling; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Product Labeling Type of study: Experimental Studies Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google